A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102)...
InsomniaThe purpose of this study is to investigate and evaluate the bioequivalence and food effect of SEP 190-102 in Japanese healthy subjects by assessing the pharmacokinetics parameters.
An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia
Primary InsomniaSecondary InsomniaThe purpose of this study is to compare an investigational drug (LY2624803) with placebo and with zolpidem in the treatment of outpatients with chronic insomnia.
A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150)
InsomniaThe purpose of this study is to evaluate the long-term safety of eszopiclone (2, 3 mg) in non-elderly patients with insomnia and eszopiclone (1, 2 mg) in elderly patients with insomnia.
Efficacy and Safety of Ramelteon Combined With Gabapentin in Treating Patients With Insomnia
Sleep Initiation and Maintenance DisordersThe purpose of this study is to determine the efficacy and safety of ramelteon, once daily (QD), taken in combination with Gabapentin for treating insomnia.
Behavioral Insomnia Therapy With Chronic Fatigue Syndrome
Chronic Fatigue SyndromeBehavioral Therapy Targeted to Sleep ProblemsThe purpose of this study is to determine how best to manage the sleep problems of people with Chronic Fatigue Syndrome. This study is being conducted to determine how improvements in sleep affect other Chronic Fatigue symptoms including pain, fatigue, and mood as well as a person's sense of general well-being.
Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug
Sleep Initiation and Maintenance DisordersThe purpose of this study is to define the absorption, breakdown and excretion of a single dose of radiolabelled SB-649868 and its breakdown products by measuring their concentration in blood, urine and faeces over a 7-10 day period. "Radiolabelled" means that the test drug has a radioactive component to help us track the drug. The safety and tolerability of the test drug will also be assessed.
A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia...
Primary InsomniaThe purpose of this study is to further explore an effective dose range of PD0200390 for the treatment of patients with insomnia.
Acupuncture for Primary Insomnia
InsomniaThis is a randomized controlled trial to evaluate acupuncture treatment on insomnia in the adult population in Hong Kong.
A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia...
Sleep Initiation and Maintenance DisordersMental Disorders4 moreTo investigate the long-term efficacy and safety of treatment with esmirtazapine (Org 50081, SCH 900265, MK-8265) compared to placebo, in participants with chronic primary insomnia. Primary efficacy variable is Total Sleep Time (TST).
A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in...
Transient InsomniaThe purpose of this study is to assess consumers' behaviors related to gabapentin self- selection and use, relative to warnings and directions for use, as described in the proposed over-the-counter (OTC) product label.
